You are here

AusPAR: insulin degludec/liraglutide

Related information


How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

15 April 2021
AusPAR Details
AusPAR
Active Ingredient
insulin degludec/liraglutide
Product Name
Xultophy
Sponsor
Novo Nordisk Pharmaceuticals Pty Ltd
Submission Number
PM 2019 05122-1-5
Submission Type
New combination of active ingredients
Decision
Approved
AusPAR Date
22 March 2021
Publication Date

15 April 2021